Amniotech is a seed stage biotech company developing a platform technology and products for the sustained delivery of protein-based therapeutics. The initial product under development should improve the effectiveness of current protein based therapeutics in healing chronic dermal wounds, thus significantly increasing the cure rates to those suffering from chronic wounds. Follow on applications of this technology and potential future products include: tailored delivery platforms for protein-based therapeutic treatment of burns, hypertrophic scaring, hair loss, bone fractures, and severed nerves
